LPL Financial
GPCR icon

LPL Financial’s Structure Therapeutics GPCR Stock Holding History

LPL Financial’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$769K Buy
14,333
+5,073
+55% +$224K ﹤0.01% 4648
2026
Q1 		$446K Buy
9,260
+1,151
+14% +$78.8K ﹤0.01% 4864
2025
Q4 		$564K Sell
8,109
-14,894
-65% -$608K ﹤0.01% 4607
2025
Q3 		$644K Buy
23,003
+11,404
+98% +$227K ﹤0.01% 4413
2025
Q2 		$241K Buy
+11,599
New +$255K ﹤0.01% 4951
2025
Q1 		– Sell
-11,485
Closed -$311K – 5426
2024
Q4 		$311K Buy
11,485
+646
+6% +$22.9K ﹤0.01% 4496
2024
Q3 		$476K Sell
10,839
-497
-4% -$19.2K ﹤0.01% 4036
2024
Q2 		$445K Buy
11,336
+2,542
+29% +$104K ﹤0.01% 3964
2024
Q1 		$377K Buy
+8,794
New +$371K ﹤0.01% 4019

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

LPL Financial's GPCR Position: Q2 2026 in Review

LPL Financial increased its Structure Therapeutics (GPCR) stake by 55% in Q2 2026, buying an estimated $224K and bringing the position to 14,333 shares worth $769K. The position accounts for ﹤0.01% of the portfolio, ranked #4648.

LPL Financial first reported a position in GPCR in Q1 2024 and has held it in 9 quarters since. 191 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • LPL Financial held 14,333 shares of Structure Therapeutics worth $769K as of Q2 2026.
  • LPL Financial bought 5,073 Structure Therapeutics shares in Q2 2026, an estimated $224K.
  • Structure Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #4648 holding.
  • LPL Financial first reported a position in Structure Therapeutics in Q1 2024 and has held it in 9 quarters since.
  • 191 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.